You can buy or sell GILD and other stocks, options, ETFs, and crypto commission-free!
Gilead Sciences, Inc. Common Stock, also called Gilead Sciences, is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Read More Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Foster City, California
52 Week High
52 Week Low
Research And Development
Gilead And Kratos Defense: 'Fast Money Halftime Report' Picks From May 23
On CNBC's "Fast Money Halftime Report", Brenda Vingiello spoke about Gilead Sciences, Inc. (NASDAQ: GILD). She said expectations for this company are very low and valuation is also low. She thinks that the new CEO should drive growth by making strategic acquisitions over time. Jon Najarian likes Kratos Defense & Security Solutions, Inc (NASDAQ: KTOS). He noticed unusual options activity and he revealed that he has a long position in the name....
Yahoo FinanceMay 21
Top Stock Reports for Disney, Coca-Cola & Gilead
Tuesday, May 21, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Coca-Cola (KO) and Gilead (GILD). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>> Scroll to continue with content Ad Disney’s shares have gained +28.7% over the past year, outperforming the Zack...
Expected Jul 25, After Hours